Document:

EX-10.2 LETTER AGREEMENT / KEVIN M. CAMERON

 

EXHIBIT 10.2

CONFORMED COPY          

[Emdeon Letterhead]

February 1, 2006

Kevin Cameron

[Address]

Dear Kevin:

Reference is made to the Employment Agreement dated September 23, 2005 (the “Employment Agreement”)
between you and Emdeon Corporation (formerly known as WebMD Corporation, the “Company”).

	 	1.	 	Termination without Cause — WebMD Health Option. (A) Section 4.4 of the
Employment Agreement is hereby amended by inserting a new clause (iv) to read as follows:

	 	(iv)	 	that portion of the option to purchase shares of WebMD Health Corp.
(“WebMD Health”) common stock granted to you on September 28, 2005 (the “WebMD
Health Option”) that would have vested on the next vesting date following the date
of termination shall be deemed vested on the date of termination and the WebMD
Health Option shall remain exercisable for the post termination exercise period
specified in the applicable option agreement plus an extension to the later of
(A) the 15th day of the third month following such post-termination
exercise period or (B) December 31 of the calendar in which such post-termination
exercise period terminates (but in no event to a date after the termination of
the original 10 year term).

(B) The first proviso immediately following clause (iv) is hereby amended by inserting the
words “and the acceleration of vesting of the next vesting of the WebMD Health Option and
the continued exercisability of the WebMD Health Option” immediately following the words
“Existing Stock Options” in the second line of such proviso.

	 	2.	 	Change in Control. (A) The second sentence of Section 4.5 of the Employment
Agreement is amended by adding after clause (iv) a new clause (v) to read as follows:

1

 

	 	 	 	“and (v) the WebMD Health Option shall be deemed fully vested on the date of
termination and the post termination exercise period shall be as specified in
Section 4.4(iv)”.

     (B) The definition of a “Change in Control” contained in the last sentence of Section 4.5
is hereby amended in its entirety to read as follows:

       “For purposes of this Agreement, a “Change in Control” shall have the meaning specified in the
Company’s 2000 Long Term Incentive Plan as in effect on the date hereof. For the avoidance of
doubt, no public offering or any split-off, spin-off or other divestiture of WebMD Health by the
Company to stockholders shall constitute a Change in Control of the Company or of WebMD Health for
purposes of the Agreement.”

     (C) Section 4.5 of the Employment Agreement is hereby amended by inserting a subsection (B)
at the end thereof:

     “(B) For purposes of this Agreement, a “Change in Control of WebMD Health” shall be deemed to
have occurred:

	 	(i)	 	when any “person”, as defined in Section 3(a)(9) of the Securities Exchange Act, and as
used in Sections 13(d) and 14(d) thereof, including a “group”, as defined in Section 13(d)
and 14(d) thereof (but excluding WebMD Health (and any successor to WebMD Health in a
transaction which did not result in a Change in Control), any subsidiary or parent of WebMD
Health and any employee benefit plan sponsored or maintained by WebMD Health or any
subsidiary or parent of WebMD Health (including any trustee of such plan acting as trustee))
directly or indirectly becomes the “beneficial owner” (as defined in Rule 13d-3 under the
Exchange Act) of securities of WebMD Health representing more than 50% of the combined
voting power of its then outstanding securities;
	 
	 	(ii)	 	when, at any time during the Employment Period, the individuals who constitute the WebMD
Health Board on the Effective Date (the “WebMD Health Incumbent Directors”) cease for any
reason to constitute at least a majority thereof; provided, however, that a director who was
not a director on February 1, 2006 shall be deemed to be a WebMD Health Incumbent Director
if such director was elected by, or on the recommendation of or with the approval of at
least a majority of the directors of WebMD Health who then qualified as WebMD Health
Incumbent Directors, either actually (because they were directors on February 1, 2006) or by
prior operation of this clause (ii);
	 
	 	(iii)	 	when there is consummated a merger or consolidation of WebMD Health with any other
corporation, other than (A) a merger or consolidation which would result in the voting
securities of WebMD Health outstanding immediately prior to such merger or consolidation
continuing to represent (either by remaining

2

 

	 	 	 	outstanding or by being converted into voting securities of the surviving entity or any
parent thereof), in combination with the ownership of any trustee or other fiduciary
holding securities under an employee benefit plan of WebMD Health or any subsidiary or
parent of WebMD Health, more than 50% of the combined voting power of the securities of
WebMD Health or such surviving entity or any parent thereof outstanding immediately
after such merger or consolidation, or (B) a merger or consolidation effected to
implement a recapitalization of WebMD Health (or similar transaction) in which no person
becomes the beneficial owner, directly or indirectly, of securities of WebMD Health
representing more than 50% of the combined voting power of WebMD Health’s then
outstanding securities;
	 
	 	(iv)	 	when there is a sale or disposition of all or substantially all of WebMD Health’s assets,
other than a sale or disposition by WebMD Health of all or substantially all of its assets
to an entity, at least 50% of the combined voting power of the outstanding securities of
which are owned by stockholders of WebMD Health in substantially the same proportions as
their ownership of WebMD Health immediately prior to such sale; or
	 
	 	(v)	 	when WebMD Health adopts a plan of complete liquidation.

In the event of the occurrence of a Change in Control of WebMD Health or WebMD Health is no longer
an Affiliate (as defined in the WebMD Health Corp. 2005 Long Term Incentive Plan) of the Company,
the WebMD Health Option shall be deemed fully vested on such date of the Change in Control of WebMD
Health or the date that the Company is no longer an Affiliate of WebMD Health and the post
termination exercise period shall be as specified in Section 4.4(iv).”

	 	3.	 	Good Reason. Section 4.6 of the Employment Agreement is amended by inserting
in the last sentence thereof “and the acceleration of vesting of the next vesting of the
WebMD Health Option and the continued exercisability of the WebMD Health Option”
immediately following the words “Existing Stock Options” in the second line of such
sentence.
	 
	 	4.	 	Permanent Disability; Death. Section 4.2 of the Employment Agreement is
amended by inserting the following sentence at the end thereof: “For the sake of clarity,
in the event that Executive’s employment is terminated as a result of his death or a
Permanent Disability following a Change in Control of the Company, Executive (or his
estate) shall be entitled to the payments and benefits specified in
Section 4.5 (or such greater benefits as may be provided in the
applicable equity plan with respect to death or Disability).”
	 
	 	5.	 	Section 409A Amendments. Section 4 of the Employment Agreement is hereby
amended by inserting a new Section 4.8 to read as follows: “Any payments (including,
without limitation, salary continuation and the payment of insurance premiums) required to
be paid to Executive pursuant to Sections 4.2, 4.4, 4.5 or 4.6 of this Agreement during the
first six months following the termination of

3

 

	 	 	 	Executive’s employment shall be paid to or on behalf of Executive in a lump sum at the end of
such six-month period in accordance with the requirements of Section 409A of the Internal
Revenue Code of 1986, as amended (“Section 409A”), provided that such delay in
payments will not apply to the extent that guidance issued under Section 409A allow payments
to be made when otherwise due without subjecting the Executive to additional taxes under
Section 409A.”

You hereby acknowledge that in no event is the Employment Agreement intended to extend the term of
any option granted to you beyond the original 10 year term applicable to the option.

By signing below you acknowledge your acceptance of this amendment. Except as set forth herein, the
Employment Agreement remains in full force and effect and is hereby ratified in all respects. All
references to the Employment Agreement shall be deemed a reference to the Employment Agreement as
amended hereby.

	 	 	 	 	 	 	 
	 	 	EMDEON CORPORATION	 	 
	 
	 	 	 	 	 	 
	 	 	     /s/ Andrew C. Corbin	 	 
	 	 	 	 	 
	 

	 	Name:

Title:
	 	Andrew C. Corbin

Executive Vice President

and Chief Financial Officer	 	 

	 	 	 
	Acknowledged and Agreed
	 	 
	 
	 	 
	/s/ Kevin M. Cameron
	 	 
	 	 	 
	Kevin Cameron
	 	 
	Dated: February 1, 2006
	 	 

	 	 	 	 	 
	WEBMD HEALTH CORP. (with respect to the

provisions related to the WebMD Health Option)
	 
	 	 	 	 
	/s/ Anthony Vuolo	 	 
	 	 	 
	Name:

Title:

	 	Anthony Vuolo

Executive Vice President and

Chief Financial Officer	 	 

4EX-10.3 LETTER AGREEMENT / MARTIN J. WYGOD

 

EXHIBIT 10.3

CONFORMED COPY          

[Letterhead of Emdeon Corporation]

February 1, 2006

Martin J. Wygod

[Address]

Dear Marty:

The purpose of this Letter Agreement is (1) to amend your Employment Agreement (the “Employment
Agreement”) dated August 3, 2005 with Emdeon Corporation (formerly known as WebMD Corporation, the
“Company”) and (2) to notify you of certain equity awards that have been granted to you.

     1. Amendment to Employment Agreement. Reference is made to your Employment
Agreement. The definition of a “Company Change in Control” contained in Section 4(b) of the
Employment Agreement is amended in its entirety to read as follows:

          “For purposes of this Agreement, a “Company Change in Control” shall have the meaning
specified in the Company’s 2000 Long Term Incentive Plan as in effect on the date hereof. For the
avoidance of doubt, no public offering or any split-off, spin-off or other divestiture of WebMD
Health by the Company to stockholders shall constitute a Company Change in Control.”

     2. Equity Grants. The Compensation Committee of the Board of Directors of Emdeon
approved the following equity grants to you on January 27, 2006 (“date of grant”):

               (a) A nonqualified option to purchase 500,000 shares of the Company’s common stock under the
Company’s 1996 Stock Plan and a nonqualified option to purchase 100,000 shares under the Company’s
2000 Long Term Incentive Plan (collectively, the “New Options”). The per share exercise
price shall be the closing price of the Company’s common stock on the date of grant and the New
Options shall vest subject to your continued employment on the applicable vesting dates (subject to
the terms of the Employment Agreement) in equal annual installments of 25% commencing on the first
anniversary of the date of grant. The New Options will have a term of ten years, subject to
earlier expiration in the event of termination of employment. The New

 

Options are “Outstanding Equity” for purposes of the Employment Agreement. Subject to the
terms of the Employment Agreement, the New Options shall be evidenced by the Company’s standard
form of option agreement.

               (b) 150,000 shares of Restricted Stock (the “Restricted Shares”) under the terms of the 2000
Long Term Incentive Plan. The Restricted Shares shall vest and the restrictions thereon lapse in
equal annual installments of 33-1/3% commencing on the first anniversary of the date of grant
subject to your continued employment on the applicable dates except as set forth in the Employment
Agreement. The Restricted Shares are “Outstanding Equity” for purposes of the Employment
Agreement. Subject to the terms of the Employment Agreement, the Restricted Shares shall be
evidenced by the Company’s standard form of restricted stock agreement.

Except as set forth herein, the Employment Agreement remains in full force and effect and is hereby
ratified in all respects. All references to the Employment Agreement shall be deemed a reference
to the Employment Agreement as amended hereby.

	 	 	 	 	 	 	 
	 	 	EMDEON CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	/s/
	 	Andrew C. Corbin	 	 
	 

	 	 	 	 	 	 
	 

	 	Name:
	 	Andrew C. Corbin
	 	 
	 

	 	Title:
	 	Executive Vice President
	 	 
	 

	 	 	 	and Chief Financial Officer	 	 

	 	 	 	 	 
	Acknowledged and Agreed	 	 
	 
	 	 	 	 
	/s/ Martin J. Wygod	 	 
	 	 	 
	Martin J. Wygod	 	 
	 
	 	 	 	 
	Dated: Februray 1, 2006	 	 

2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00096-of-00352.parquet"}]]